Sulfasalazine

Articles · Medicine Compliance Aid Stability · Lactation Safety Information ·

45844004

Articles

Safety in Lactation: Drugs which suppress the rheumatic disease process

Disease-modifying anti-rheumatic drugs (DMARDs) have a varied pharmacology, mainly either modifying the immune response to the disease or modifying the disease process. The choice of… Abatacept Adalimumab Anakinra Azathioprine Belimumab Certolizumab pegol Chloroquine Ciclosporin Etanercept Golimumab Hydroxychloroquine Infliximab Leflunomide Methotrexate Penicillamine Rituximab Sodium aurothiomalate Sulfasalazine Tocilizumab Ustekinumab

Medicine Compliance Aid Stability

Salazopyrin EN · Pharmacia Ltd

Pharmacia Ltd
Salazopyrin EN
Tablets e/c 500mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers and protect from light.
22nd October 2015

Salazopyrin · Pfizer Ltd

Pfizer Ltd
Salazopyrin
Tablets 500mg
A2 · Amber 2 · No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light.
22nd October 2015

Salazopyrin EC · Pharmacia Ltd

Pharmacia Ltd
Salazopyrin EC
Tablets e/c 500mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light in well closed containers.
27th November 2015

Salazopyrin · Pharmacia Ltd

Pharmacia Ltd
Salazopyrin
Salazopyrin
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light in well closed containers.
27th November 2015

Lactation Safety Information

for inflammatory bowel disease

for inflammatory bowel disease
Mesalalzine
19th May 2016

for rheumatoid arthritis

for rheumatoid arthritis
See summary
Mesalazine, which is an active metabolite of sulfasalazine, has been associated with a small number of possible cases of diarrhoea in breastfed infants. An additional case of sulfasalazine-related bloody diarrhoea has also been reported
Its sulfapyridine metabolite presents a theoretical risk of neonatal haemolysis, especially in G6PD-deficient infants
Monitor infant for diarrhoea